Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Pfizer
West Virginia University
OHSU Knight Cancer Institute
Alpha Tau Medical LTD.
Novartis
Turnstone Biologics, Corp.
Charite University, Berlin, Germany
University of Massachusetts, Worcester
Washington University School of Medicine
McGill University Health Centre/Research Institute of the McGill University Health Centre
National Cancer Institute (NCI)
Apexigen America, Inc.
Clinigen, Inc.
Dana-Farber Cancer Institute
Nektar Therapeutics
Bristol-Myers Squibb
Idera Pharmaceuticals, Inc.
University Hospitals Cleveland Medical Center
Exicure, Inc.
Barco NV
Dynavax Technologies Corporation
Clinigen, Inc.
Centre Hospitalier Universitaire de Saint Etienne
Fox Chase Cancer Center
Dartmouth-Hitchcock Medical Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Celldex Therapeutics
Aprea Therapeutics
CureOne
Incyte Corporation
Stanford University
sigma-tau i.f.r. S.p.A.
Stanford University
New Mexico Cancer Research Alliance
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
The Cleveland Clinic
University of Zurich
National Institutes of Health Clinical Center (CC)
MELA Sciences, Inc.
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
New Mexico Cancer Research Alliance